About the ETRO Studies
3700 Patients. 40+ Countries.
If you still have symptoms of Ulcerative Colitis or Crohn’s even though you’ve received treatment for your condition, you may be eligible to participate in the Etro Studies. Our teams of professionals have worked tirelessly to make this enrollment phase of the study possible.
Here’s a quick overview of what the studies entail.
Why Participate in a Clinical Trial?
- You may get expert medical care from leading specialists and nurses throughout the study
- You’ll receive medication for up to 7 years, at no cost, if you are eligible and choose to participate in the open-label extension
- You remain in control of your level of participation
- You contribute to scientific understanding of Ulcerative Colitis and Crohn’s disease
Interested in taking part in the Etro Studies? Find out if the Etro Studies could be right for you.